Scarica l'app Stockscreener
261.91
0.45%
1.17
Pre-mercato:
262.00
0.09
+0.03%
Natera Inc Borsa (NTRA) Ultime notizie
U.S. Supreme Court Rejects CareDxA’s Appeal in Natera, Inc. (NTRA) False-advertising Dispute - Insider Monkey
Price-Driven Insight from (NTRA) for Rule-Based Strategy - Stock Traders Daily
Form 4 Natera Inc For: 26 June By Investing.com - Investing.com Nigeria
Natera director Herm Rosenman sells $4.13m in common stock - Investing.com UK
Natera(NTRA.US) Officer Sells US$8.46 Million in Common Stock - Moomoo
Insider Sell Alert: Herm Rosenman Sells 16,530 Shares of Natera Inc (NTRA) - GuruFocus
Natera Inc (NTRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Natera legal officer Daniel Rabinowitz sells $8.45m in shares - Investing.com
Natera legal officer Daniel Rabinowitz sells $8.45m in shares By Investing.com - Investing.com South Africa
Natera director Herm Rosenman sells $4.13m in common stock By Investing.com - Investing.com South Africa
Natera (NTRA) director’s 10b5-1 sale leaves 4,250 shares - Stock Titan
Natera (NTRA) chief legal officer sells 33,600 shares in pre-set 10b5-1 trades - Stock Titan
Bernstein resumes Natera stock coverage with outperform rating By Investing.com - Investing.com South Africa
Natera (NTRA) Partners With Eledon To Put Prospera Into Phase 3 Kidney Trial - simplywall.st
Natera (NTRA) Receives Outperform Rating and $310 Target from Be - GuruFocus
Natera: All-Time Share Price High A Potential Caveat For Investors, Despite Promise - Seeking Alpha
Bernstein resumes Natera stock coverage with outperform rating - Investing.com UK
What's Driving Natera's Recent Stock Action, and Why Are Insiders Selling - Kavout | AI
NTRA Reiterated by Bernstein -- Price Target Announced at $310 - GuruFocus
Bernstein Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $310 - Moomoo
What's Driving Natera's Recent Stock Action - Kavout | AI
Natera, Inc. Actuals & Estimates (NASDAQ:NTRA) - TradingView
Banu Saritas-Yildirim: Signatera is Approved in Japan by FDA - Oncodaily
Eledon Teams Up With Natera on Phase 3 Study - Orange County Business Journal
NTRA Forecast — Price Target — Prediction for 2027 - TradingView
NTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in Japan - The Globe and Mail
Natera’s Prospera test selected for Eledon kidney transplant trial - Investing.com UK
Goldman Sachs Maintains Natera(NTRA.US) With Hold Rating, Maintains Target Price $245 - Moomoo
Natera, Eledon Partner to Use Prospera in Phase 3 Kidney Transplant Trial - Moomoo
Natera’s Prospera test selected for Eledon kidney transplant trial By Investing.com - Investing.com Nigeria
Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar? - Yahoo Finance
Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial - TradingView
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial - Business Wire
Barclays Maintains Natera(NTRA.US) With Buy Rating, Cuts Target Price to $260 - Moomoo
Biotech Medical Test Leader Hits Record High, Joins 15 Others New To Best Stock Lists - Investor's Business Daily
Form 144 NATERA For: 24 June By Investing.com - Investing.com Nigeria
[144] Natera, Inc. SEC Filing - Stock Titan
This Medtech Stock Just Flashed A Buy Signal; Here's Why - Investor's Business Daily
Natera NTRA Jumps As NCCN Endorsement Fuels Bullish Targets - StocksToTrade
Why Natera (NTRA) Stock Is Up Today - Yahoo Finance
Natera Inc stock hits all-time high at 256.57 USD By Investing.com - Investing.com Australia
NTRA Maintained by BTIG -- Price Target Raised to $275 - GuruFocus
Natera Stock Jumps As NCCN Endorses Signatera MRD Test - timothysykes.com
Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer - Benzinga
Natera (NTRA) Achieves First MRD Test Approval in Japan - GuruFocus
Natera Surges As Signatera Wins Big Cancer Milestones - TipRanks
Natera (NTRA) Is Up 6.7% After First PMDA-Approved MRD Test in JapanWhat's Changed - simplywall.st
Natera Inc stock hits all-time high at 256.57 USD - Investing.com
0.66%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):